RecruitingNCT04394052
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II: Texture Analysis and Artificial Intelligence
Sponsor
Central Hospital, Nancy, France
Enrollment
740 participants
Start Date
Jun 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients suspected to have a bone or soft-tissue tumor referred for imaging for initial tumors characterization and staging.
Exclusion Criteria5
- Pregnancy
- Breast feeding patients
- Renal insufficiency
- Contra indications to MRI or CT
- Prior surgery or treatment to the evaluated lesion.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTMR imaging
Medical imaging
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04394052
Related Trials
Prospective Registry of Histotripsy for Soft Tissue Tumors
NCT074700081 location
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
NCT034424653 locations
Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial
NCT070620031 location
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NCT038898991 location
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NCT045341271 location